Citadel Advisors
NBP

Citadel Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Citadel Advisors’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.7K Buy
+34,700
New +$70.8K ﹤0.01% 12957
2026
Q1 		– Sell
-10,000
Closed -$39.8K – 13567
2025
Q4 		$39.8K Sell
10,000
-400
-4% -$1.77K ﹤0.01% 12137
2025
Q3 		$39.3K Buy
10,400
+200
+2% +$679 ﹤0.01% 12302
2025
Q2 		$24.7K Sell
10,200
-9,800
-49% -$13.3K ﹤0.01% 12056
2025
Q1 		$16.5K Buy
+20,000
New +$19K ﹤0.01% 13280
2024
Q4 		– Sell
-56,400
Closed -$69.9K – 14909
2024
Q3 		$69.9K Buy
56,400
+53,400
+1,780% +$66.9K ﹤0.01% 11559
2024
Q2 		$5.01K Sell
3,000
-8,900
-75% -$15.9K ﹤0.01% 13437
2024
Q1 		$22.1K Buy
11,900
+11,400
+2,280% +$21K ﹤0.01% 12941
2023
Q4 		$950 Sell
500
-7,900
-94% -$11.8K ﹤0.01% 13913
2023
Q3 		$11.1K Sell
8,400
-1,300
-13% -$2.85K ﹤0.01% 13027
2023
Q2 		$29K Sell
9,700
-2,800
-22% -$8.99K ﹤0.01% 12390
2023
Q1 		$43.3K Sell
12,500
-5,600
-31% -$27.1K ﹤0.01% 12350
2022
Q4 		$75.7K Buy
18,100
+7,200
+66% +$27.3K ﹤0.01% 11593
2022
Q3 		$44K Sell
10,900
-11,800
-52% -$89.5K ﹤0.01% 11719
2022
Q2 		$257K Sell
22,700
-50,800
-69% -$609K ﹤0.01% 10161
2022
Q1 		$1.19M Buy
73,500
+62,900
+593% +$1.61M ﹤0.01% 7299
2021
Q4 		$502K Buy
10,600
+400
+4% +$24K ﹤0.01% 9687
2021
Q3 		$739K Sell
10,200
-1,800
-15% -$130K ﹤0.01% 8918
2021
Q2 		$1.01M Buy
+12,000
New +$792K ﹤0.01% 8358

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors's NBP Position: Q2 2026 in Review

Citadel Advisors increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 274% in Q2 2026, buying an estimated $930K and bringing the position to 622,831 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #7726.

Citadel Advisors first reported a position in NBP in Q4 2020 and has held it in 16 quarters since. The position peaked at $3.63M in Q4 2020. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Citadel Advisors held 622,831 shares of NovaBridge Biosciences American Depositary Shares worth $1.21M as of Q2 2026.
  • Citadel Advisors bought 456,215 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $930K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7726 holding.
  • Citadel Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 16 quarters since.
  • Citadel Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $3.63M in Q4 2020.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.